Abbott Labs (NYSE:ABT) has seen strong revenue growth in the recent past, primarily reflecting the impact of acquisitions it made over the last couple of years. The company's Diagnostics business will likely see a double digit growth for the full year 2018, reflecting the impact of the Alere...
Abbott Labs (NYSE:ABT) has seen strong revenue growth in the recent past, primarily reflecting the impact of acquisitions it made over the last couple of years. The company's Diagnostics business will likely see a double digit growth for the full year 2018, reflecting the impact of the Alere...
Share this Article
Recommended